Xanthine/alpha-ketoglutarate (alphaKG) dioxygenase (XanA) is a non-heme mononuclear Fe(II) enzyme that decarboxylates alphaKG to succinate and CO(2) while hydroxylating xanthine to generate uric acid. In the absence of a XanA crystal structure, a homology model was used to target several putative active site residues for mutagenesis. Wild-type XanA and ten enzyme variants were purified from recombinant Escherichia coli cells and characterized. The H149A and D151A variants were inactive and the H340A variant exhibited only 0.17% of the wild-type enzyme activity, consistent with the proposed role of His149, Asp151, and His340 as Fe ligands. The K122A variant led to a 2-fold increase in the K(d) of alphaKG as measured by fluorescence quenching analysis, in agreement with Lys122 acting to stabilize the binding of alphaKG. The N358A variant exhibited a 23-fold decrease in k(cat)/K(m) compared to wild-type XanA, pointing to a key role of Asn358 in catalysis. 9-Methylxanthine was exploited as an alternate substrate, and the C357A, E137A, and D138A variants were found to exhibit relatively enhanced activity consistent with Cys357, Glu137, and Asp138 being proximal to N-9 or involved in its proper positioning. 6,8-Dihydroxypurine was identified as a slow-binding competitive inhibitor of XanA, and significant decreases (E137A and D138A) or increases (Q356A and N358A) in K(i)(app) of the variants were interpreted in terms of distinct interactions between this compound and the corresponding active site side chains. Further support for Cys357 residing at the active site was obtained using thiol-specific reagents that inactivated wild-type enzyme (with partial protection by substrate), whereas the C357A variant was resistant to these reagents. The Q101A, Q356A, and C357A variants showed elevated ferroxidase activity in the absence of substrates, pointing to the presence of the corresponding side chains at the active site. These results confirm most aspects of the homology model and provide additional insight into the enzyme reactivity.

译文

黄嘌呤/α-酮戊二酸 (αkg) 双加氧酶 (XanA) 是一种非血红素单核Fe(II) 酶,可将 αkg脱羧为琥珀酸和CO(2),同时将黄嘌呤羟基化以生成尿酸。在没有XanA晶体结构的情况下,使用同源性模型来靶向几个推定的活性位点残基进行诱变。从重组大肠杆菌细胞中纯化野生型XanA和十种酶变体并进行了表征。H149A和D151A变体是无活性的,H340A变体仅表现出0.17% 的野生型酶活性,这与His149,Asp151和His340作为Fe配体的拟议作用一致。通过荧光猝灭分析测得,K122A变体导致 αkg的K(d) 增加了2倍,这与Lys122起稳定 αkg结合的作用一致。与野生型XanA相比,N358A变体的k(cat)/K(m) 降低了23倍,表明Asn358在催化中的关键作用。利用9-甲基黄嘌呤作为替代底物,发现C357A,E137A和D138A变体表现出相对增强的活性,与Cys357,Glu137和Asp138接近N-9或参与其正确定位一致。6,8-二羟基嘌呤被鉴定为XanA的慢结合竞争性抑制剂,并且变体的K(i)(app) 中的显着降低 (E137A和D138A) 或增加 (Q356A和N358A) 解释为该化合物与相应活性位点侧链之间的不同相互作用。使用使野生型酶失活的硫醇特异性试剂 (通过底物部分保护) 获得了驻留在活性位点的Cys357的进一步支持,而C357A变体对这些试剂具有抗性。Q101A,Q356A和C357A变体在不存在底物的情况下显示出更高的铁氧化酶活性,表明在活性位点存在相应的侧链。这些结果证实了同源模型的大多数方面,并提供了对酶反应性的更多了解。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录